Latest News and Press Releases

Certara today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution.

Lewes, Delaware, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The Global Cell Culture Market Size is projected to grow at a CAGR of 14.23% from 2026 to 2032, according to a new report published by Verified...

Certara appoints Dr. Chris Bouton as Chief Technology Officer to advance AI in-silico drug discovery and development platform.

CERTARA APPOINTS DR. ADRIAN MCKEMEY AS PRESIDENT OF DRUG DEVELOPMENT SOLUTIONS

NEWARK, Del, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The global peptone market is projected to grow steadily, with sales estimated at USD 846.4 million in 2024 and expected to reach USD 1,299.0 million by...

Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.

Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.

Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.

Certara today announced the launch of Phoenix™ version 8.5 software, the pharmaceutical industry's gold standard in PK/PD modeling and simulation.

Certara has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software.